Speaker Bio & Presentations

Dr. David Nutt

Special Speaker

Professor David Nutt

David Nutt is Chair of the Drug Science Scientific Committee and currently the Edmund J Safra Professor of Neuropsychopharmacology and Head of the Neuropsychopharmacology Unit in the Centre for Academic Psychiatry in the Division of Brain Sciences, Dept of Medicine, Hammersmith Hospital, Imperial College London. He is also visiting professor at the Open University in the UK and Maastricht University in the Netherlands. He is the founder of Drug Science and has held many leadership positions in both the UK and European academic scientific and clinical organizations. These include presidencies of the European Brain Council, the British Neuroscience Association, the British Association of Psychopharmacology and the European College of Neuropsychopharmacology as well as Chair of the UK Advisory Council on the Misuse of Drugs. He is a Fellow of the Royal Colleges of Physicians, of Psychiatrists and of the Academy of Medical Sciences. He is also the UK Director of the European Certificate and Masters in Affective Disorders courses and a member of the International Centre for Science in Drug Policy.

David has edited the Journal of Psychopharmacology for over twenty five years and acts as the psychiatry drugs advisor to the British National Formulary. He has published over 500 original research papers and a similar number of reviews and books chapters, eight government reports on drugs and 35 books, including one for the general public, ‘Drugs Without the Hot Air’, which won the Transmission book prize in 2014 for Communication of Ideas.

Presentations & Workshops

Are Illegal Drugs the Future of Mental Health and Addiction Treatments?

The last two decades have seen a massive increase in innovation research relating to drugs that were (and in most cases still are) banned under the UN Conventions and national drugs legislation. Many of these drugs, particularly the psychedelics such as psilocybin and LSD had been shown to have significant benefits for mental health and addictions before they were banned in the 1960s/70s These early observations have since been confirmed with new studies of psilocybin in depression and addictions. More recently cannabis ketamine and MDMA have revealed efficacy in disorders such as PTSD depression and addiction. We are now in a new era of psychedelic-psychotherapy that offers a major advance for many patients who hitherto have not responded well to conventional treatments. Also, brain imaging research now helps us understand how these drugs work to facilitate the person engaging with the therapeutic process and why the impact of just one or two psychedelic interventions can lead to long-term benefits.

See More Speakers

Dr. Deepak
Chopra

Dr. Gabor
Maté

Dr. Peter
Levine

Rob
Lowe

Marianne
Williamson

Dr. Constant
Mouton

Dr. Karol
Darsa

Prof. David
Nutt

Dr. Tian
Dayton

Dr. James
Flowers

Andrew Lovell /
Anthony Gorry

Dr. Alberto
Pertusa

David
Curtis

Dr. Neil
Brener

Professor
John Kelly

Dr. Louis
Cox

Dr. Matthew
Walker

Kristin
Kirkpatrick

Antonello
Bonci

Dr. Claudia
Black

Dr. Derick
Anderson, PsyD.

Jim
Soda

Margaret
Trudeau

Dr. Richard
Schwartz

Dr. Annie
Peters

Dr. Jacki
Hillios

Dr. Kara
Fitzgerald

Dr. Dawn
Nickel

Dr. Debbie
Boeldt

Dr. Deran
Young

Stephen Porges /
Deb Dana

Jaime
Vinck

Dr. Marc
Milstein

Matthew
Vogl

Nicole
Golden

Dr. Stefanie
Carnes

Dr. Anna
Lembke

Beck Gee-Cohan/
Jordan Held

Kelley
Kitley

Peter
Lazar

Annelies
Richmond

Dr. Sarah
Polley

Judy
Crane

Russell
Brand

Ester
Nicholson

Pete
Nielsen

Antonello
Bonci

Dr. Nicholas Hayes /
Annie Peters

Kristina
Padilla

Gabby
Bernstein

Reserve Your Spot

Click below to register for the 2022 Global Exchange Conference while seats are available!

Global Exchange logo

Contact:

DBA: Exchange Events Inc
Phone: (844) 572-7250
Email: info@theglobalexchangeconference.com

About:

The GXC Conference 2022 is dedicated to professionals who want to elevate their knowledge regarding therapeutic practices, treatment models, and the latest mental health, addiction, and wellness innovations.

As to Disney properties/artwork: © Disney  |  Sitemap  |  Privacy Policy